{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:58:46Z","timestamp":1792155526657,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF19033"],"award-info":[{"award-number":["MCRF19033"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","award":["1145028"],"award-info":[{"award-number":["1145028"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peninsula Oncology"},{"name":"Australian Government Research Training Program scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41590-024-02014-5","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:04:19Z","timestamp":1732183459000},"page":"2259-2269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A STAT3\u2013STING\u2013IFN axis controls the metastatic spread of small cell lung cancer"],"prefix":"10.1038","volume":"25","author":[{"given":"Aleks C.","family":"Guanizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinton","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Samantha N.","family":"Jayasekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline D.","family":"de Geus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Inampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Senyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"de Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony Y.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Gantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J.","family":"Balic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surein","family":"Arulananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Garama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hertzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Ganju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Neil","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-1735","authenticated-orcid":false,"given":"Daniel J.","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"2014_CR1","unstructured":"Forman, D. et al. (eds) Cancer Incidence in Five Continents Volume X (IARC, 2014)."},{"key":"2014_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin, C. M. et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer 19, 289\u2013297 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2014_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay, C. M. et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39, 346\u2013360 (2021).","journal-title":"Cancer Cell"},{"key":"2014_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","volume":"36","author":"ML Burr","year":"2019","unstructured":"Burr, M. L. et al. An evolutionarily conserved function of Polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell 36, 385\u2013401 (2019).","journal-title":"Cancer Cell"},{"key":"2014_CR5","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","volume":"11","author":"NR Mahadevan","year":"2021","unstructured":"Mahadevan, N. R. et al. Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity. Cancer Discov. 11, 1952\u20131969 (2021).","journal-title":"Cancer Discov."},{"key":"2014_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan, J. M. et al. Signatures of plasticity, metastasis and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 39, 1479\u20131496 (2021).","journal-title":"Cancer Cell"},{"key":"2014_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","volume":"19","author":"J Huynh","year":"2019","unstructured":"Huynh, J., Chand, A., Gough, D. & Ernst, M. Therapeutically exploiting STAT3 activity in cancer\u2014using tissue repair as a road map. Nat. Rev. Cancer 19, 82\u201396 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2014_CR8","doi-asserted-by":"publisher","first-page":"314ra185","DOI":"10.1126\/scitranslmed.aac5272","volume":"7","author":"D Hong","year":"2015","unstructured":"Hong, D. et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Transl. Med. 7, 314ra185 (2015).","journal-title":"Sci. Transl. Med."},{"key":"2014_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47\u201353 (2015).","journal-title":"Nature"},{"key":"2014_CR10","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1128\/MCB.02404-06","volume":"27","author":"J Azare","year":"2007","unstructured":"Azare, J. et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin \u03b26. Mol. Cell. Biol. 27, 4444\u20134453 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"2014_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","volume":"31","author":"G Mollaoglu","year":"2017","unstructured":"Mollaoglu, G. et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition. Cancer Cell 31, 270\u2013285 (2017).","journal-title":"Cancer Cell"},{"key":"2014_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41388-021-02070-3","volume":"41","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. Oncogene 41, 138\u2013145 (2022).","journal-title":"Oncogene"},{"key":"2014_CR13","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/modpathol.2011.150","volume":"25","author":"WD Travis","year":"2012","unstructured":"Travis, W. D. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod. Pathol. 25, S18\u2013S30 (2012).","journal-title":"Mod. Pathol."},{"key":"2014_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3892\/ol.2012.792","volume":"4","author":"K Nakazawa","year":"2012","unstructured":"Nakazawa, K. et al. Specific organ metastases and survival in small cell lung cancer. Oncol. Lett. 4, 617\u2013620 (2012).","journal-title":"Oncol. Lett."},{"key":"2014_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cell.2016.05.052","volume":"166","author":"SK Denny","year":"2016","unstructured":"Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328\u2013342 (2016).","journal-title":"Cell"},{"key":"2014_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington, N. D., Cursons, J. & Rautela, J. The cancer\u2013natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437\u2013454 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2014_CR17","doi-asserted-by":"publisher","first-page":"24391","DOI":"10.1016\/S0021-9258(19)51096-1","volume":"269","author":"R Raz","year":"1994","unstructured":"Raz, R., Durbin, J. E. & Levy, D. E. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons and growth factors. J. Biol. Chem. 269, 24391\u201324395 (1994).","journal-title":"J. Biol. Chem."},{"key":"2014_CR18","doi-asserted-by":"publisher","first-page":"e1314424","DOI":"10.1080\/2162402X.2017.1314424","volume":"6","author":"M Musella","year":"2017","unstructured":"Musella, M., Manic, G., De Maria, R., Vitale, I. & Sistigu, A. Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications. Oncoimmunology 6, e1314424 (2017).","journal-title":"Oncoimmunology"},{"key":"2014_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni1213","volume":"6","author":"GP Dunn","year":"2005","unstructured":"Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722\u2013729 (2005).","journal-title":"Nat. Immunol."},{"key":"2014_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788\u2013792 (2009).","journal-title":"Nature"},{"key":"2014_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"CH Yu","year":"2020","unstructured":"Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell 183, 636\u2013649 (2020).","journal-title":"Cell"},{"key":"2014_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","volume":"9","author":"T Sen","year":"2019","unstructured":"Sen, T. et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 9, 646\u2013661 (2019).","journal-title":"Cancer Discov."},{"key":"2014_CR23","doi-asserted-by":"publisher","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","volume":"41","author":"I Rusinova","year":"2013","unstructured":"Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040\u2013D1046 (2013).","journal-title":"Nucleic Acids Res."},{"key":"2014_CR24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224\u20131231 (2012).","journal-title":"Nat. Med."},{"key":"2014_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3727\/096504016X14756226781802","volume":"25","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y. et al. Overexpression of interferon regulatory factor 7 (IRF7) reduces bone metastasis of prostate cancer cells in mice. Oncol. Res 25, 511\u2013522 (2017).","journal-title":"Oncol. Res"},{"key":"2014_CR26","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1126\/science.1171721","volume":"324","author":"DJ Gough","year":"2009","unstructured":"Gough, D. J. et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324, 1713\u20131716 (2009).","journal-title":"Science"},{"key":"2014_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7285","volume":"6","author":"B Grabner","year":"2015","unstructured":"Grabner, B. et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat. Commun. 6, 6285 (2015).","journal-title":"Nat. Commun."},{"key":"2014_CR28","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.4049\/jimmunol.165.7.3571","volume":"165","author":"C-K Lee","year":"2000","unstructured":"Lee, C.-K. et al. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165, 3571 (2000).","journal-title":"J. Immunol."},{"key":"2014_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jtho.2020.05.008","volume":"15","author":"SA Best","year":"2020","unstructured":"Best, S. A. et al. Harnessing natural killer immunity in metastatic SCLC. J. Thorac. Oncol. 15, 1507\u20131521 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"2014_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2017.12.007","volume":"48","author":"A Glasner","year":"2018","unstructured":"Glasner, A. et al. NKp46 receptor-mediated interferon-\u03b3 production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity 48, 107\u2013119 (2018).","journal-title":"Immunity"},{"key":"2014_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature20792","volume":"541","author":"L van der Weyden","year":"2017","unstructured":"van der Weyden, L. et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 541, 233\u2013236 (2017).","journal-title":"Nature"},{"key":"2014_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843\u2013852 (2014).","journal-title":"Immunity"},{"key":"2014_CR33","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208, 1989\u20132003 (2011).","journal-title":"J. Exp. Med."},{"key":"2014_CR34","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830\u2013842 (2014).","journal-title":"Immunity"},{"key":"2014_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 (2018).","journal-title":"Nature"},{"key":"2014_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature18268","volume":"533","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Carcinoma\u2013astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533, 493\u2013498 (2016).","journal-title":"Nature"},{"key":"2014_CR37","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"key":"2014_CR38","doi-asserted-by":"publisher","first-page":"E4612","DOI":"10.1073\/pnas.1705499114","volume":"114","author":"H Yang","year":"2017","unstructured":"Yang, H., Wang, H., Ren, J., Chen, Q. & Chen, Z. J. cGAS is essential for cellular senescence. Proc. Natl Acad. Sci. USA 114, E4612\u2013E4620 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2014_CR39","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","volume":"25","author":"L Ding","year":"2018","unstructured":"Ding, L. et al. PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian cancer. Cell Rep. 25, 2972\u20132980 (2018).","journal-title":"Cell Rep."},{"key":"2014_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","volume":"71","author":"G Dunphy","year":"2018","unstructured":"Dunphy, G. et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-\u03baB signaling after nuclear DNA damage. Mol. Cell 71, 745\u2013760 (2018).","journal-title":"Mol. Cell"},{"key":"2014_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 (2017).","journal-title":"Nature"},{"key":"2014_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","volume":"79","author":"J Shen","year":"2019","unstructured":"Shen, J. et al. PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness. Cancer Res. 79, 311\u2013319 (2019).","journal-title":"Cancer Res."},{"key":"2014_CR43","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","volume":"6","author":"GP Dunn","year":"2006","unstructured":"Dunn, G. P., Koebel, C. M. & Schreiber, R. D. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6, 836\u2013848 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"2014_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41590-024-01960-4","volume":"25","author":"NM Haynes","year":"2024","unstructured":"Haynes, N. M., Chadwick, T. B. & Parker, B. S. The complexity of immune evasion mechanisms throughout the metastatic cascade. Nat. Immunol. 25, 1793\u20131808 (2024).","journal-title":"Nat. Immunol."},{"key":"2014_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/CMR.0b013e3282f0c893","volume":"18","author":"C Garbe","year":"2008","unstructured":"Garbe, C. et al. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res. 18, 61\u201367 (2008).","journal-title":"Melanoma Res."},{"key":"2014_CR46","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2174\/092986711795471293","volume":"18","author":"MT Pirrotta","year":"2011","unstructured":"Pirrotta, M. T., Bernardeschi, P. & Fiorentini, G. Targeted-therapy in advanced renal cell carcinoma. Curr. Med. Chem. 18, 1651\u20131657 (2011).","journal-title":"Curr. Med. Chem."},{"key":"2014_CR47","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn, L. et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N. Engl. J. Med. 379, 2220\u20132229 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2014_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/JTO.0000000000000414","volume":"10","author":"H Ishii","year":"2015","unstructured":"Ishii, H. et al. Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer. J. Thorac. Oncol. 10, 426\u2013430 (2015).","journal-title":"J. Thorac. Oncol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02014-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T10:03:46Z","timestamp":1732615426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02014-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2014"],"URL":"https:\/\/doi.org\/10.1038\/s41590-024-02014-5","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}